Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines. 2010

Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.

In previous studies, we have shown overexpression and ectopic subcellular distribution of gamma-tubulin and betaIII-tubulin in human glioblastomas and glioblastoma cell lines (Katsetos et al., 2006, J Neuropathol Exp Neurol 65:455-467; Katsetos et al., 2007, Neurochem Res 32:1387-1398). Here we determined the expression of gamma-tubulin in surgically excised medulloblastomas (n = 20) and in the human medulloblastoma cell lines D283 Med and DAOY. In clinical tissue samples, the immunohistochemical distribution of gamma-tubulin labeling was pervasive and inversely related to neuritogenesis. Overexpression of gamma-tubulin was widespread in poorly differentiated, proliferating tumor cells but was significantly diminished in quiescent differentiating tumor cells undergoing neuritogenesis, highlighted by betaIII-tubulin immunolabeling. By quantitative real-time PCR, gamma-tubulin transcripts for TUBG1, TUBG2, and TUBB3 genes were detected in both cell lines but expression was less prominent when compared with the human glioblastoma cell lines. Immunoblotting revealed comparable amounts of gamma-tubulin and betaIII-tubulin in different phases of cell cycle; however, a larger amount of gamma-tubulin was detected in D283 Med when compared with DAOY cells. Interphase D283 Med cells exhibited predominantly diffuse cytoplasmic gamma-tubulin localization, in addition to the expected centrosome-associated distribution. Robust betaIII-tubulin immunoreactivity was detected in mitotic spindles of DAOY cells. Our data indicate that overexpression of gamma-tubulin may be linked to phenotypic dedifferentiation (anaplasia) and tumor progression in medulloblastomas and may potentially serve as a promising tumor marker.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008527 Medulloblastoma A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1) Arachnoidal Cerebellar Sarcoma, Circumscribed,Medulloblastoma, Desmoplastic,Medullomyoblastoma,Sarcoma, Cerebellar, Circumscribed Arachnoidal,Medulloblastoma, Adult,Medulloblastoma, Childhood,Melanocytic Medulloblastoma,Adult Medulloblastoma,Adult Medulloblastomas,Childhood Medulloblastoma,Childhood Medulloblastomas,Desmoplastic Medulloblastoma,Desmoplastic Medulloblastomas,Medulloblastoma, Melanocytic,Medulloblastomas,Medulloblastomas, Adult,Medulloblastomas, Childhood,Medulloblastomas, Desmoplastic,Medulloblastomas, Melanocytic,Medullomyoblastomas,Melanocytic Medulloblastomas
D008941 Spindle Apparatus A microtubule structure that forms during CELL DIVISION. It consists of two SPINDLE POLES, and sets of MICROTUBULES that may include the astral microtubules, the polar microtubules, and the kinetochore microtubules. Mitotic Apparatus,Mitotic Spindle Apparatus,Spindle Apparatus, Mitotic,Meiotic Spindle,Meiotic Spindle Apparatus,Mitotic Spindle,Apparatus, Meiotic Spindle,Apparatus, Mitotic,Apparatus, Mitotic Spindle,Apparatus, Spindle,Meiotic Spindles,Mitotic Spindles,Spindle Apparatus, Meiotic,Spindle, Meiotic,Spindle, Mitotic,Spindles, Meiotic,Spindles, Mitotic
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms

Related Publications

Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
October 1995, Neuropathology and applied neurobiology,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
May 2006, Journal of neuropathology and experimental neurology,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
September 1986, Journal of the National Cancer Institute,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
January 2009, Molecular cancer therapeutics,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
February 1996, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
January 2002, Cancer treatment and research,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
May 2010, Molecular cancer therapeutics,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
December 2005, Biochemistry,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
January 1997, Anticancer research,
Valentina Caracciolo, and Luca D'Agostino, and Eduarda Dráberová, and Vladimíra Sládková, and Catena Crozier-Fitzgerald, and Dimitri P Agamanolis, and Jean-Pierre de Chadarévian, and Agustin Legido, and Antonio Giordano, and Pavel Dráber, and Christos D Katsetos
January 2003, Cell biology international,
Copied contents to your clipboard!